Interstitial Lung Disease in a Patient Treated with Denosumab
Denosumab is an antiresorptive agent widely used for treating osteoporosis. Atypical femur fractures, osteonecrosis of the jaw and hypocalcaemia are well-known possible adverse effects of this drug. We present, to our knowledge, the first case report in the English literature of clinically significa...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2019-07-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1131 |